Skip to content
buyNotable

Yin Yan bought $2.5M of BIOE

Chief Executive Officer at Bio Essence Corp. 5,000,000 shares at an average of $0.50, traded Jun 6, 2023, filed Oct 11, 2024.

Conviction score
60
Value
$2.5M
5,000,000 shares
Holdings after
14,000,000
+56% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    CEO
    +25
  • Trade size
    $2.5M at market
    +25
  • Relative to holdings
    Holdings up 56%
    +10
  • Price context
    No price history yet
    0
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -91.1%, 3m -92.8%, 6m -93.1%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

BIOEOct 9, 2026 · close 0.27
Since filing Oct 11, 2024: -91.4%SPY +37.4% · excess -128.7%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001213900-24-087183, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jun 6, 2023POpen-market purchase
Common Stock
+5,000,000$0.50$2.5M14,000,000Oct 11, 2024

Related signals

Other insiders at Bio Essence Corp and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
62Notable
BIOEsell
Bio Essence Corp
Yin Yan
Chief Executive Officer
$455k
323,845 shares
-67%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Yin Yan bought $2.5M of BIOE | InsiderTell